This clinical trial is focused on patients who have undergone heart surgery, specifically those with conditions like coronary artery disease, aortic valve disease, mitral valve disease, tricuspid valve disease, or a combination of these. The study is investigating the effects of a medication called oxycodone, which is used for pain relief. Oxycodone will be administered through a method called PCA, or patient-controlled analgesia, which allows patients to manage their pain by controlling the amount of medication they receive.
The purpose of the study is to evaluate how oxycodone affects breathing after heart surgery. Researchers will monitor patients’ oxygen levels and breathing patterns to understand any changes that occur with the use of oxycodone. The study will also look at how much oxycodone is used and its concentration in the blood. Additionally, the study will assess pain levels, any complications from surgery, and overall quality of life after the surgery.
Participants in the study will receive either oxycodone or a placebo. The study will take place over a period of time, with regular check-ins to monitor the effects of the medication. The goal is to gather information on both the short-term and long-term outcomes of using oxycodone for pain management after heart surgery.



Finland